TrademarkDir
INFLAZOME TARGETED THERAPIES FOR INFLAMMATORY DISEASES
LIVE

Serial Number

79208982

Owner

INFLAZOME LIMITED

Attorney

JANET G RICCIUTI

Filing Date

Feb 3, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

INFLAZOME TARGETED THERAPIES FOR INFLAMMATORY DISEASES Trademark

Serial Number: 79208982 • Registration: 5592355

INFLAZOME TARGETED THERAPIES FOR INFLAMMATORY DISEASES is a trademark filed by INFLAZOME LIMITED on February 3, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

INFLAZOME LIMITED (2 trademarks)

88 Harcourt Street

Entity Type: 11

Trademark Details

Filing Date

February 3, 2017

Registration Date

October 30, 2018

Published for Opposition

August 14, 2018

Cancellation Date

May 16, 2025

Goods & Services

Diagnostic apparatus not for medical purposes; computer software in the field of diagnosis; laboratory apparatus and instruments

Apparatus and instruments for medical diagnosis

Diagnostic preparations for medical use; reagents for use in diagnostic tests for medical purposes; medical preparations and articles

Chemical reagents for scientific use; chemical diagnostic reagent for industrial use

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Sep 3, 2026 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Aug 18, 2026 INTS
INVALIDATION PROCESSED
Aug 18, 2026 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 16, 2026 INTR
CANCELLED SECTION 71
May 16, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 30, 2023 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Nov 14, 2019 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 22, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 6, 2019 FICS
FINAL DISPOSITION PROCESSED
Feb 5, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 30, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 30, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 14, 2018 NPUB
PUBLISHED FOR OPPOSITION
Aug 14, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Aug 11, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 25, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 25, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 25, 2018 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 9, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 9, 2018 XAEC
ASSIGNED TO LIE
Jul 9, 2018 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 7, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 7, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 7, 2018 CNEA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jan 13, 2018 GPRN
PRIORITY ACTION E-MAILED
Jan 13, 2018 GPRA
PRIORITY ACTION WRITTEN
Jan 13, 2018 CPRA
DATA MODIFICATION COMPLETED
Dec 30, 2017 DMCC
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 21, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 21, 2017 CRFA
ASSIGNED TO LIE
Dec 19, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 12, 2017 TROA
REFUSAL PROCESSED BY IB
Jul 8, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 18, 2017 RFCS
REFUSAL PROCESSED BY MPU
Jun 17, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 11, 2017 RFCR
NON-FINAL ACTION WRITTEN
Jun 10, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Jun 9, 2017 MAFR
ASSIGNED TO EXAMINER
Jun 6, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 5, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 1, 2017 REPR

Related Trademarks

More from this Owner

INFLAZOME

INFLAZOME

INFLAZOME

INFLAZOME

INFLAZOME

INFLAZOME